We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

11 hedge funds and large institutions have $799K invested in NeuroMetrix, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

15% less funds holding

Funds holding: 1311 (-2)

21% less capital invested

Capital invested by funds: $1.01M → $799K (-$213K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
11
Holders Change
-2
Holders Change %
-15.38%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
3
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q4 2018 in Review

11 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2018, worth a combined $799K — down 21% from $1.01M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NURO and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Sabby Management, adding an estimated $304K. The largest seller was Millennium Management, exiting entirely with an estimated $59K sold.

  • 11 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2018, down from 13 in Q3 2018.
  • Funds reported $799K of NeuroMetrix, Inc. Common Stock stock for Q4 2018, down 21% quarter-over-quarter.
  • 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2018 and 3 closed out, a net change of -1 holder.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2018 was Sabby Management, an estimated $304K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q4 2018 was Millennium Management, an estimated $59K sold.

Based on aggregated 13F filings for Q4 2018.